1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
a2 Pilot Awards is sponsored by National Institute on Aging (NIA) AITC program (managed by the a2 Collective). A national pilot project competition providing non-dilutive R&D grant funding for technology demonstration projects with a clear path to commercialization, translational milestones, or technology transfer at the intersection of AI, healthy aging, or AD/ADRD.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
AI AgeTech Non-Dilutive R&D Funding for Startups + Academics The a2 Collective represents the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program, which is dedicated to helping Americans live longer, healthier lives through the application of artificial intelligence (AI) and emerging technologies.
To date, the AITC program has funded 166 AI-driven AgeTech projects with more than $40M to improve care and health outcomes for older adults, including persons with Alzheimer’s disease and related dementias (AD/ADRD).
Pilot awardees may receive access to study sites, datasets, and resources at each AITC, as well as mentorship from industry and university experts, major health systems, and venture capitalists, and are eligible to apply for $10K in AWS credits . Pilot awardees may also become more competitive for SBIR/STTR grant funding . The AITC program is funded by the National Institute on Aging (NIA), part of the National Institutes of Health.
MORE INFO: a2collective. ai/symposium From Grants to Growth: When Early-Stage Health Tech Should Pursue Angel Investment Best Practices for Digital Phenotyping Research in Aging Populations Considerations for Planning and Submitting a Pre-Determined Change Control Plan for AI-Enabled Devices Become an Entrepreneur in Residence: Live, Learn, and Innovate in a Senior Living Community Automating Ageism: AI, Care, & Aging Futures From Dec.
2, 2024, to Jan. 15, 2025, the a2 Collective is accepting applications for our fifth annual a2 Pilot Awards, a national pilot project competition seeking to provide non-dilutive R&D grant funding to promising technology demonstration projects with a clear path to commercialization, translational milestones, or technology transfer at the intersection of AI, healthy aging, or AD/ADRD.
Private companies, research organizations, tech startups , and traditional NIH/NIA investigators are encouraged to apply. The a2 Collective anticipates sharing updates regarding the next a2 Pilot Awards competition in mid- to late 2026, contingent upon renewal of the National Institute on Aging (NIA) AITC program. KEY DATES - FIFTH ANNUAL a2 PILOT AWARDS Applications Open: 01.
10. 22 Applications Close: 02. 18.
22 Round 1 Applications Open: Q&A Webinar with AITC Leadership: Dec 9, 2024 @ 12-1 p. m. ET Round 1 Applications Deadline: Round 2 (Invite-Only) Applications Deadline: Projects Expected to Begin: America is getting older faster.
By 2034, 77 million Americans will be 65 or older. They will make up the largest age demographic in the United States, outnumbering Americans under 18 for the first time ever. The application of AI technologies will dramatically improve the health and quality of life of our nation’s aging population as well as drive innovation to our healthcare systems.
The a2 Collective sits at the intersection of this once-in-a-generation opportunity. The a2 Collective comprises three AITC Collaboratories centered at Johns Hopkins University (JH AITC), the University of Massachusetts Amherst (MassAITC), and the University of Pennsylvania (PennAITech) and the a2 Collective Coordinating Center managed by Rose Li and Associates, Inc. (RLA) .
Johns Hopkins Artificial Intelligence and Technology Collaboratory for Aging Research Massachusetts AI & Technology Center for Connected Care in Aging & Alzheimer's Disease Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center Have a question about media, partnerships, or pilot awards? Want to get on our mailing list?
We’d love to hear from you! How did you hear of the a2 Collective? Thank you!
Your submission has been received! Oops! Something went wrong while submitting the form.
Applying for the Pilot Awards Partner with the a2 Collective Accelerator Partner/Mentor
According to the current listing, eligibility includes: Private companies, research organizations, tech startups, and traditional NIH/NIA investigators. Confirm the full requirements in the official notice before applying.
The current listing shows up to $200,000 (direct costs for 12 months). Verify award ceilings, matching requirements, and allowable costs in the official notice.
a2 Pilot Awards is funded by National Institute on Aging (NIA) AITC program (managed by the a2 Collective). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article